• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚嗪类抗癌剂的最新研究进展。

Recent Advances in the Development of Indazole-based Anticancer Agents.

机构信息

School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai, China.

出版信息

ChemMedChem. 2018 Aug 10;13(15):1490-1507. doi: 10.1002/cmdc.201800253. Epub 2018 Jun 26.

DOI:10.1002/cmdc.201800253
PMID:29863292
Abstract

Cancer is one of the leading causes of human mortality globally; therefore, intensive efforts have been made to seek new active drugs with improved anticancer efficacy. Indazole-containing derivatives are endowed with a broad range of biological properties, including anti-inflammatory, antimicrobial, anti-HIV, antihypertensive, and anticancer activities. In recent years, the development of anticancer drugs has given rise to a wide range of indazole derivatives, some of which exhibit outstanding activity against various tumor types. The aim of this review is to outline recent developments concerning the anticancer activity of indazole derivatives, as well as to summarize the design strategies and structure-activity relationships of these compounds.

摘要

癌症是全球导致人类死亡的主要原因之一;因此,人们已经做出了巨大努力,以寻求具有更好抗癌效果的新型活性药物。含吲唑的衍生物具有广泛的生物学特性,包括抗炎、抗菌、抗 HIV、抗高血压和抗癌活性。近年来,抗癌药物的发展产生了多种吲唑衍生物,其中一些对各种肿瘤类型具有突出的活性。本文综述了吲唑衍生物的抗癌活性的最新研究进展,并对这些化合物的设计策略和构效关系进行了总结。

相似文献

1
Recent Advances in the Development of Indazole-based Anticancer Agents.吲哚嗪类抗癌剂的最新研究进展。
ChemMedChem. 2018 Aug 10;13(15):1490-1507. doi: 10.1002/cmdc.201800253. Epub 2018 Jun 26.
2
Indazole Derivatives: Promising Anti-tumor Agents.吲唑衍生物:有前景的抗肿瘤药物。
Anticancer Agents Med Chem. 2018;18(9):1228-1234. doi: 10.2174/1871520618666180510113822.
3
Design, Synthesis and Biological Evaluation of 6-(2,6-Dichloro-3,5-dimethoxyphenyl)-4-substituted-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors.6-(2,6-二氯-3,5-二甲氧基苯基)-4-取代-1H-吲唑作为强效成纤维细胞生长因子受体抑制剂的设计、合成及生物学评价
Molecules. 2016 Oct 23;21(10):1407. doi: 10.3390/molecules21101407.
4
Indazole derivatives and their therapeutic applications: a patent review (2013-2017).吲唑衍生物及其治疗用途:专利审查(2013-2017)。
Expert Opin Ther Pat. 2018 Jun;28(6):441-453. doi: 10.1080/13543776.2018.1472240. Epub 2018 May 11.
5
Pharmacological properties of indazole derivatives: recent developments.吲唑衍生物的药理特性:最新进展
Mini Rev Med Chem. 2005 Oct;5(10):869-78. doi: 10.2174/138955705774329564.
6
The Anticancer Activity of Indazole Compounds: A Mini Review.吲唑类化合物的抗癌活性:小型综述。
Curr Top Med Chem. 2021;21(5):363-376. doi: 10.2174/1568026620999201124154231.
7
Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors.新型抗血管生成剂的发现。第8部分:含1H-吲唑-3-胺的二芳基硫脲作为多靶点受体酪氨酸激酶抑制剂
Eur J Med Chem. 2017 Dec 1;141:373-385. doi: 10.1016/j.ejmech.2017.10.008. Epub 2017 Oct 6.
8
Design, synthesis and biological evaluation of novel FGFR inhibitors bearing an indazole scaffold.含吲唑骨架的新型成纤维细胞生长因子受体(FGFR)抑制剂的设计、合成及生物学评价
Org Biomol Chem. 2015 Jul 28;13(28):7643-54. doi: 10.1039/c5ob00778j. Epub 2015 Jun 17.
9
Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines.基于吲唑的二芳基脲衍生物的合成及其对肿瘤细胞系的抗增殖活性。
Bioorg Med Chem Lett. 2013 Apr 1;23(7):1989-92. doi: 10.1016/j.bmcl.2013.02.034. Epub 2013 Feb 15.
10
Design and synthesis of 1H-indazole-3-carboxamide derivatives as potent and selective PAK1 inhibitors with anti-tumour migration and invasion activities.作为具有抗肿瘤迁移和侵袭活性的有效且选择性PAK1抑制剂的1H-吲唑-3-甲酰胺衍生物的设计与合成
Eur J Med Chem. 2020 Oct 1;203:112517. doi: 10.1016/j.ejmech.2020.112517. Epub 2020 Jul 6.

引用本文的文献

1
Recent Advances in the Mitsunobu and Related Reactions: A Review from 2010 to 2024.光延反应及相关反应的最新进展:2010年至2024年综述
Top Curr Chem (Cham). 2025 Mar 18;383(2):15. doi: 10.1007/s41061-025-00501-3.
2
Trastuzumab Potentiates Antitumor Activity of Thiopyrano[2,3-]Thiazole Derivative in AGS Gastric Cancer Cells.曲妥珠单抗增强噻吩并[2,3-]噻唑衍生物在 AGS 胃癌细胞中的抗肿瘤活性。
Molecules. 2024 Oct 30;29(21):5117. doi: 10.3390/molecules29215117.
3
Regioselective alkylation of a versatile indazole: Electrophile scope and mechanistic insights from density functional theory calculations.
一种通用吲唑的区域选择性烷基化:亲电试剂范围及密度泛函理论计算的机理见解
Beilstein J Org Chem. 2024 Aug 9;20:1940-1954. doi: 10.3762/bjoc.20.170. eCollection 2024.
4
Thioamides in medicinal chemistry and as small molecule therapeutic agents.硫代酰胺在药物化学中以及作为小分子治疗剂。
Eur J Med Chem. 2024 Nov 5;277:116732. doi: 10.1016/j.ejmech.2024.116732. Epub 2024 Aug 5.
5
Innovative cascade reaction for 2H-indazole derivative synthesis.用于合成2H-吲唑衍生物的创新级联反应。
Mol Divers. 2025 Feb;29(1):551-559. doi: 10.1007/s11030-024-10874-0. Epub 2024 May 26.
6
Visible-Light-Driven Decarboxylative Coupling of 2-Indazoles with α-Keto Acids without Photocatalysts and Oxidants.可见光驱动的2-吲唑与α-酮酸的脱羧偶联反应,无需光催化剂和氧化剂
J Org Chem. 2024 May 3;89(9):6159-6168. doi: 10.1021/acs.joc.4c00176. Epub 2024 Apr 20.
7
Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance.作为P-糖蛋白(P-gp/ABCB1)抑制剂用于逆转多药耐药的WK-X-34衍生物的合成与评价
RSC Med Chem. 2023 Dec 7;15(2):506-518. doi: 10.1039/d3md00612c. eCollection 2024 Feb 21.
8
Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemia.基于吲哚的FLT3抑制剂及相关骨架作为急性髓系白血病的潜在治疗药物。
BMC Chem. 2023 Jul 12;17(1):73. doi: 10.1186/s13065-023-00981-8.
9
PROTACs in the Management of Prostate Cancer.PROTACs 在前列腺癌治疗中的应用。
Molecules. 2023 Apr 25;28(9):3698. doi: 10.3390/molecules28093698.
10
2-Aminobenzothiazoles in anticancer drug design and discovery.2-氨基苯并噻唑在抗癌药物设计与发现中的应用。
Bioorg Chem. 2023 Jun;135:106477. doi: 10.1016/j.bioorg.2023.106477. Epub 2023 Mar 20.